Market Place
Sourcing Support
SK Life Science Unveils XCOPRI® Data on Dual Mechanism at AES 2024
08 Dec 2024 //
PR NEWSWIRE
Dr. Sunita Selected as Fellow of the American Epilepsy Society
02 Dec 2024 //
PR NEWSWIRE
SK Life Presents Cenobamate Research at 2024 AES Annual Meeting
25 Nov 2024 //
PR NEWSWIRE
XCOPRI® Approved For Alternate Oral, Nasogastric Tube Use
11 Apr 2024 //
PR NEWSWIRE
SK Life: XCOPRI® Data At AAN 2024
09 Apr 2024 //
PR NEWSWIRE
SK Life Science touts epilepsy support programs for Purple Day
25 Mar 2024 //
FIERCE PHARMA
SK Life Science Publishes Updated Real-World Experience on Cenobamate
13 Mar 2024 //
PR NEWSWIRE
SK Life Science to Host Symposium and Present New Data at AES
28 Nov 2023 //
PR NEWSWIRE
SK Life Science sets up an indoor rainstorm to point to Xcopri`s full coverage
21 Apr 2023 //
ENDPTS
Latest XCOPRI® (cenobamate tablets) CV Post-hoc Analysis Presented at the ANN
17 Apr 2023 //
PR NEWSWIRE
SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV
02 Dec 2022 //
PRNEWSWIRE
SK life science To Present Latest XCOPRI® (cenobamate tablets) CV Data
28 Nov 2022 //
PRNEWSWIRE
Long-Term Efficacy and Safety Data of XCOPRI CV Published in Neurology
22 Jun 2022 //
PRNEWSWIRE
SK Life Sci kicks Xcopri sales into high gear with new campaign
24 May 2022 //
FIERCEPHARMA
SK life science Presents Long-term Data on Adverse Events Associated with XCOPRI
31 Mar 2022 //
PRNEWSWIRE
SK life science to Present Latest XCOPRI CV Data at AAN 2022
24 Mar 2022 //
PRNEWSWIRE
SK life science Initiates Phase 3 Clinical Trial of Carisbamate for LGS
06 Jan 2022 //
PRNEWSWIRE
Social media mavens join SK Life’s latest epilepsy awareness ads
04 Aug 2021 //
FIERCEPHARMA
SK Life’s dual TV ads for Xcopri target both docs and patients
13 May 2021 //
FIERCEPHARMA
SK life science To Present Latest Cenobamate Data at the American Academy
08 Apr 2021 //
PRNEWSWIRE
SK Life Science debuts Xcopri virtual experience for HCPs
15 Dec 2020 //
FIERCEPHARMA
SK life science Presents Latest Cenobamate Data at the American Epilepsy
01 Dec 2020 //
PRNEWSWIRE
SK life science Presents Latest Cenobamate Data at the American Epilepsy
01 Dec 2020 //
PRNEWSWIRE
SK life science Expands Support for the Epilepsy Foundation to Advance Epilepsy
15 Jul 2020 //
PRNEWSWIRE
SK Life Science, Inc. Announces FDA Acceptance of IND Application SKL24741
02 Dec 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.